From housekeeper to microsurgeon : The diagnostic and therapeutic potential of ribonucleasesSCHEIN, C. H.Nature biotechnology. 1997, Vol 15, Num 6, pp 529-536, issn 1087-0156Article

A cytotoxic ribonuclease : study of the mechanism of onconase cytotoxicityYOUNENG WU; MIKULSKI, S. M; ARDELT, W et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 14, pp 10686-10693, issn 0021-9258Article

Sustained and cancer cell targeted cytosolic delivery of Onconase results in potent antitumor effectsHONG LIANG ZHAO; CHONG XUE; JI LIANG DU et al.Journal of controlled release. 2012, Vol 159, Num 3, pp 346-352, issn 0168-3659, 7 p.Article

Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitorMIKULSKI, S. M; VIERA, A; DEPTALA, A et al.International journal of oncology. 1998, Vol 13, Num 4, pp 633-644, issn 1019-6439Article

Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stressARDELT, B; JUAN, G; ARDELT, W et al.International journal of oncology. 2007, Vol 31, Num 3, pp 663-669, issn 1019-6439, 7 p.Article

RNA damage and inhibition of neoplastic endothelial cell growth : Effects of human and amphibian ribonucleasesNEWTON, Dianne L; KAUR, Gurmeet; RHIM, Johng S et al.Radiation research. 2001, Vol 155, Num 1, pp 171-174, issn 0033-7587, 2Conference Paper

Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamilyVASANDANI, V. M; WU, Y.-N; MIKULSKI, S. M et al.Cancer research (Baltimore). 1996, Vol 56, Num 18, pp 4180-4186, issn 0008-5472Article

Effect of Onconase on Double-stranded RNA In VitroSAXENA, Abha; SAXENA, Shailendra K; SHOGEN, Kuslima et al.Anticancer research. 2009, Vol 29, Num 4, pp 1067-1071, issn 0250-7005, 5 p.Article

Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonucleaseRYBAK, S. M; PEARSON, J. W; LONGO, D. L et al.Journal of the National Cancer Institute. 1996, Vol 88, Num 11, pp 747-753, issn 0027-8874Article

Toxicity of an antitumor ribonuclease to Purkinje neuronsNEWTON, D. L; WALBRIDGE, S; MIKULSKI, M et al.The Journal of neuroscience. 1994, Vol 14, Num 2, pp 538-544, issn 0270-6474Article

Ribonucleases as potential modalities in anticancer therapyARDELT, Wojciech; ARDELT, Barbara; DARZYNKIEWICZ, Zbigniew et al.European journal of pharmacology. 2009, Vol 625, Num 1-3, pp 181-189, issn 0014-2999, 9 p.Article

Combined effects of onconase and IFN-β on proliferation, macromolecular syntheses and expression of STAT-1 in JCA-1 cancer cellsTSAI, S. Y; HSIEH, T. C; ARDELT, B et al.International journal of oncology. 2002, Vol 20, Num 5, pp 891-896, issn 1019-6439Article

Reversible nephrotoxicity of onconase and effect of lysine pH on renal onconase uptakeVASANDANI, V. M; BURRIS, J. A; SUNG, C et al.Cancer chemotherapy and pharmacology. 1999, Vol 44, Num 2, pp 164-169, issn 0344-5704Article

Potentiation of tumor necrosis factor induced apoptosis by onconaseDEPTALA, A; HALICKA, H. D; ARDELT, B et al.International journal of oncology. 1998, Vol 13, Num 1, pp 11-16, issn 1019-6439Article

Enhancement of activation-induced apoptosis of lymphocytes by the cytotoxic ribonuclease onconase (Ranpirnase)HALICKA, D. H; POZAROWSKI, P; ITA, M et al.International journal of oncology. 2002, Vol 21, Num 6, pp 1245-1250, issn 1019-6439, 6 p.Article

Tumoricidal effects of Onconase on various tumorsINTAE LEE; LEE, Y. H; MIKULSKI, S. M et al.Journal of surgical oncology. 2000, Vol 73, Num 3, pp 164-171, issn 0022-4790Article

G, arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16^INK4A, p21^WAF1/CIP1 and p27^KIP and decreased pRb phosphorylationJUAN, G; ARDELT, B; LI, X et al.Leukemia. 1998, Vol 12, Num 8, pp 1241-1248, issn 0887-6924Article

Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancerLEE, Intae; SHOGEN, Kuslima.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 337-346, issn 0344-5704, 10 p.Article

Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-κBTSAR, Shwu Y; ARDELT, Barbara; HSIEH, Tze-Chen et al.International journal of oncology. 2004, Vol 25, Num 6, pp 1745-1752, issn 1019-6439, 8 p.Article

Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude miceLEE, Intae; KALOTA, Anna; GEWIRTZ, Alan M et al.Anticancer research. 2007, Vol 27, Num 1A, pp 299-307, issn 0250-7005, 9 p.Article